Browsing publications by Professor Philip Home

Newcastle AuthorsTitleYearFull text
Professor Philip Home
Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management Reflections From a Diabetes Care Editors' Expert Forum2014
Professor Philip Home
Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin2014
Professor Philip Home
Investigational new insulin glargine U300: glucose control and hypoglycaemia in people with Type 2 diabetes using a basal plus mealtime insulin regimen (EDITION I)2014
Professor Philip Home
New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)2014
Professor Philip Home
Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014; 37: 1499-15082014
Professor Philip Home
RESPONSE TO COMMENT ON HOME ET AL. Predictive and Explanatory Factors of Change in HbA(1c) in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs. Diabetes Care 2014;37:1237-12452014
Professor Philip Home
The vexed question of hypoglycaemia and health economics2014
Professor Philip Home
52-week efficacy of albiglutide vs placebo and vs pioglitazone in triple therapy (background metformin and glimepiride) in patients with type 2 diabetes: HARMONY 5 study2013
Professor Philip Home
A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetes2013
Professor Philip Home
Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L)2013
12345678910111213141516171819